Sign Up to like & get
recommendations!
0
Published in 2017 at "Gene Therapy"
DOI: 10.1038/gt.2017.79
Abstract: Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerations
read more here.
Keywords:
access spinraza;
spinraza nusinersen;
spinal muscular;
muscular atrophy ... See more keywords